A Study of Prevalence of HER3 Expression in Non-Small Cell Lung Cancer

CompletedOBSERVATIONAL

Enrollment

225

Participants

Timeline

Start Date

December 19, 2022

Primary Completion Date

April 6, 2023

Study Completion Date

April 6, 2023

Conditions

Non-small Cell Lung Cancer

Interventions

OTHER

Archival tissue specimen and immunohistochemistry staining

This is a non-interventional study and no intervention will be administered.

Trial Locations (2)

McLeod Health, Florence

Baptist Health South Florida - Miami Cancer Institute, Miami